Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program

BACKGROUND: In four randomized, controlled, European trials, dienogest 2 mg once daily demonstrated significant efficacy for lesion reduction and reduction in pain intensity in endometriosis. We describe a pooled analysis of the safety and tolerability data from these trials to confirm and further c...

Descripción completa

Detalles Bibliográficos
Autores principales: Strowitzki, Thomas, Faustmann, Thomas, Gerlinger, Christoph, Schumacher, Ulrike, Ahlers, Christiane, Seitz, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403681/
https://www.ncbi.nlm.nih.gov/pubmed/25926759
http://dx.doi.org/10.2147/IJWH.S77202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403681/
https://www.ncbi.nlm.nih.gov/pubmed/25926759
http://dx.doi.org/10.2147/IJWH.S77202

Ejemplares similares